UCB’s Bimekizumab Abstract
UCB is ready to present bimekizumab’s results from BE MOBILE 1 for non-radiographic axial spondyloarthritis (nr-axSpA), BE MOBILE 2 for ankylosing spondylitis (AS), and BE COMPELTE study for psoriatic arthritis (PsA).
This year, the EULAR (European Congress of Rheumatology) 2022 will be held virtually and in-pace in Copenhagen, which will be providing the first-ever hybrid congress experience. Among the access presentations planned for EULAR 2022, we have chosen something of supreme importance.
Bimekizumab is a humanized monoclonal IgG1 antibody that is planned for particular and directly inhibiting interleukin 17A (IL-17A) and interleukin 17F (IL-17F) and other two key cytokines driving inflammatory processes.
UCB will be presenting data for evaluating bimekizumab in treating active nr-axSpA and AS from the two Phase III studies, BE MOBILE 1 and BE MOBILE 2. Bimekizumab showed maintenance of clinical response over three years in patients with active AS, according to the data from the open-label extension of the Phase IIb BE AGILE study, and the same data will be presented at the EULAR conference this year.
Patients who were treated with bimekizumab (160 mg every four weeks ) achieved analytically significant and clinically relevant improvements in the signs and symptoms of axSpA in BE MOBILE 1 and BE MOBILE 2. For PsA, Bimekizumab is in Phase III clinical development, which will be used to treat active psoriatic arthritis within a 24-week interval, as per the analysis from the OPTIMAL study, and a 16-week analysis from the BE COMPLETE is to be presented at the EULAR 2022 conference.
Conclusion
For the treatment of ankylosing spondylitis, Bimekizumab is the first humanized monoclonal IgG1. The competitors of Bimekizumab in the AS space are - Abbvie’s Rinvoq (upadacitinib), Eli Lilly’s Taltz (ixekizumab), and Pfizer Xelijanz (tofacitinib), among others.
For more detailed information visit: https://www.delveinsight.com/eular-conference/eular-2022
Some of the Latest Abstracts launched in EULAR 2022:
Report Offerings by DelveInsight:
Diagnostic Imaging Equipment Market
Diagnostic Imaging Equipment Market By Product (X-Ray Imaging Systems, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Systems, Mammography Systems, And Others), By Application (Cardiology, Oncology, Gastroenterology, Gynecology, And Other Applications), By End-User (Hospitals, Diagnostic Imaging Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases.
Invasive Candidiasis Market
"DelveInsight’s ‘Invasive Candidiasis Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Invasive Candidiasis and the historical and forecasted Invasive Candidiasis market trends, globally, which comprises North America, Europe, APAC, and RoW.
Sialidosis Market
DelveInsight's "Sialidosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology as well as the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Filgrastim Biosimilar Insight
DelveInsight’s, “Filgrastim Biosimilar Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in the Filgrastim Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Pain Management Devices Market
Pain Management Devices Market By Type Of Devices (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices And Cryoablation Devices], And Others), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027.
To know more about our Competitive Services, Click here: Pharma Competitive Intelligence
Also, take a glance at our Blog Section:
How Metaverse is Set to Transform the Healthcare Dynamics?
Role of Mobile Technology in Hemophilia Management
How 3D Bioprinting Technology is Revolutionizing the Healthcare Industry?
How Cloud Computing is Transforming the Healthcare Industry Dynamics?
TheBusinessResearchCompany published its Iron Ore Mining Global Market Report 2019 which provides strategists, marketers and senior management with the critical information they need to assess the global iron ore mining market.
The report covers the iron ore mining market’s segments- construction, manufacturing, and others.Explore Complete Report https://www.thebusinessresearchcompany.com/report/iron-ore-mining-global-market-reportIron Ore Mining Global Market Report 2019 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 50+ geographies.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country.
It covers all the regions, key developed countries and major emerging markets.
The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.Request to get the sample of this report https://www.thebusinessresearchcompany.com/sample.aspx?id=2022=smpThe use of autonomous hauling systems (AHS) trucks in the iron ore mining industry is significantly enhancing production efficiency and reducing turnaround time.
These are the major trends witnessed in the global iron ore mining market.Get Discount On This Report https://www.thebusinessresearchcompany.com/sample.aspx?id=2022=discountChapters from Table of Content:Chapter 1.
The Business Research Company published its Iron Ore Mining Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global iron ore mining market.
View Complete Report: https://www.thebusinessresearchcompany.com/report/iron-ore-mining-global-market-reportIron Ore Mining Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country.
It covers all the regions, key developed countries and major emerging markets.
The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The iron mining market consists of sales of iron ores and concentrates by entities (organizations, sole traders and partnerships) that mine iron ore.
Winners of KBC Lottery 2022, KBC Lottery Winner 2022, KBC Lottery Winner, KBC fortunate Draw 2022, KBC fortunate Draw, KBC Whatsapp number, Lottery 2022, KBC Lottery Winner 2022, KBC lucky Winner, KBC Whatsapp range, KBC Lottery 25 Lakh, KBC 25 Lakh Lottery, Kaun Banega Crorepati fortunate Winners 2022, KBC Lottery 25 Lakhs 2022, KBC 25 Lakh Lottery, KBC Whatsapp wide variety, KBC Lottery 25 Lakhs, KBC 25 Lakh Lottery, KBC Winner list 2022, KBC on-line fortunate Draw, KBC All India lucky Draw 2022, Vodafone Lottery Winner 2022, Vodafone
At Safe Simple Secure, we are delighted to have been chosen as one of the Scottish Government’s partners on their new Fire Alarm campaign about the new fire detection law.We can help you ensure your home fully complies with the new law that comes into effect from February 2022.
